ESR1 and breast carcinoma: In one study, Madhavi et al. compared the growth and metastasis of estrogen receptor negative (ER−) breast cancer cell lines (MDA-MB-231, SUM1315, CN34BrM) and an ER+ cell line (T47D) in immune mice.